| TLPH |
TALPHERA, INC. |
23 Oct 2025 |
2 |
$0 |
4 |
Director |
24 Oct 2025, 16:45 |
| AKBA |
Akebia Therapeutics, Inc. |
10 Jun 2025 |
2 |
$0 |
4 |
Director |
11 Jun 2025, 17:16 |
| TLPH |
TALPHERA, INC. |
24 Jun 2024 |
2 |
$0 |
4 |
Director |
24 Jun 2024, 19:12 |
| AKBA |
Akebia Therapeutics, Inc. |
06 Jun 2024 |
2 |
$0 |
4 |
Director |
10 Jun 2024, 16:18 |
| TLPH |
ACELRX PHARMACEUTICALS INC |
10 Oct 2023 |
2 |
$0 |
4 |
Director |
13 Dec 2023, 16:19 |
| AKBA |
Akebia Therapeutics, Inc. |
06 Jun 2023 |
2 |
$0 |
4 |
Director |
08 Jun 2023, 16:07 |
| /report/000120919123010243-adams-adrian-2023-02-14 |
IMPEL PHARMACEUTICALS INC |
14 Feb 2023 |
1 |
$0 |
4 |
COB, CEO and President, Director |
16 Feb 2023, 17:19 |
| TLPH |
ACELRX PHARMACEUTICALS INC |
15 Jul 2022 |
2 |
$0 |
4 |
Director |
15 Jul 2022, 19:31 |
| AKBA |
Akebia Therapeutics, Inc. |
08 Jun 2022 |
2 |
$0 |
4 |
Director |
09 Jun 2022, 16:56 |
| /report/000120919122005445-adams-adrian-2022-01-26 |
IMPEL NEUROPHARMA INC |
26 Jan 2022 |
1 |
$0 |
4 |
COB, CEO and President, Director |
28 Jan 2022, 16:01 |
| /report/000120919121052595-adams-adrian-2021-08-18 |
IMPEL NEUROPHARMA INC |
18 Aug 2021 |
3 |
+$279,790 |
4 |
COB, CEO and President, Director |
19 Aug 2021, 17:23 |
| /report/000120919121048217-adams-adrian-2021-07-20 |
IMPEL NEUROPHARMA INC |
20 Jul 2021 |
1 |
$0 |
4 |
COB, CEO and President, Director |
26 Jul 2021, 17:58 |
| TLPH |
ACELRX PHARMACEUTICALS INC |
17 Jun 2021 |
2 |
$0 |
4 |
Director |
17 Jun 2021, 17:32 |
| AKBA |
Akebia Therapeutics, Inc. |
02 Jun 2021 |
2 |
$0 |
4 |
Director |
03 Jun 2021, 17:27 |